Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

May 23, 2015 12:19 AM ET


Company Overview of Acorda Therapeutics, Inc.

Executive Profile

Ron Cohen M.D.

Founder, Chief Executive Officer, President and Director, Acorda Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Ron Cohen, M.D., is the Founder of Acorda Therapeutics, Inc. and has been its Chief Executive Officer and President since 1995. Dr. Cohen served as Principal in the startup of Advanced Tissue Sciences, Inc. He served as the Chairman Emeritus of the New York Biotechnology Association and served as its Chairman and Director. Dr. Cohen serves as the Chairman of Emerging Company Section at the Biotechnology Industry Organization (BIO). He served as the Chairman of Acorda ...

Corporate Headquarters

420 Saw Mill River Road
Ardsley, New York 10502

United States

Phone: 914-347-4300
Fax: 914-347-4560

Board Members Memberships

Former Director
Chairman of Emerging Companies Section and Director
Founder, Chief Executive Officer, President and Director
Director and Member of Compensation Committee
Director, Member of Audit Committee and Member of Compensation Committee


Princeton University
Edward S. Harkness Eye Institute

Other Affiliations

Annual Compensation

Total Annual Compensation$745,833

Stocks Options

Restricted Stock Awards$700,413
All Other Compensation$7,650
Exercised Options$51,265
Exercised Options Value$1,404,180
Exercisable Options$837,810
Unexercisable Options$196,972
Total Value of Options$1,404,180
Total Number of Options$1,086,047

Total Compensation

Total Annual Cash Compensation$1,405,083
Total Short Term Compensation$745,833
Other Long Term Compensation$708,063
Total Calculated Compensation$4,045,181

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Inc.
Stanley T. Crooke M.D., Ph.D.Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee
Isis Pharmaceuticals, Inc.
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
Stephen R. Davis J.D.Interim Chief Executive Officer, Chief Financial Officer, Chief Business Officer and Executive Vice President
ACADIA Pharmaceuticals Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Acorda Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at